Evidence map›Paper›PMID 40529342›Full record

ArticleResearch and practice in thrombosis and haemostasis2025

Genetic analysis using long-read sequencing to overcome the difficulties in

Sheng Ye, Yuka Eura, Masanori Matsumoto, Koichi Kokame

Abstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sheng YeDepartment of Molecular Pathogenesis, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Yuka EuraDepartment of Molecular Pathogenesis, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Masanori MatsumotoDepartment of Blood Transfusion Medicine and Hematology, Nara Medical University, Kashihara, Nara, Japan.
Koichi KokameDepartment of Molecular Pathogenesis, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Genetic defects in von Willebrand factor (VWF) can lead to von Willebrand disease (VWD). Identifying causative or modifier variants of Objectives: This study aimed to establish a long-read sequencing method using Oxford nanopore technology (ONT) to overcome difficulties associated with Methods: Genetic analyses were established using genomic DNA from a healthy donor and validated using 3 VWF disorder patient samples. Long-range (∼15 kb) polymerase chain reaction was optimized to obtain 21 amplicons covering the entire Results: The entire Conclusion: This study presents an optimal solution using ONT nanopore sequencing to identify variants in

Indexed as

nanopore sequencingpolymerase chain reactionvon Willebrand diseasevon Willebrand factor

Identifiers

PMID40529342
PMCPMC12173654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.